News

The pivotal double-blinded trial was designed to assess the safety and efficacy of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prosta te cancer (CRPC).

The placebo-controlled, randomized 24-month study was designed to demonstrate the safety and efficacy of DiaPep277 in newly diagnosed patients with T1D. The study met primary endpoint defined as

GLPG0634 is a selective inhibitor of JAK1 (Janus kinase 1) used for treating inflammatory conditions like rheumatoid arthritis (RA). In the four week, proof-of-concept trial involving 36 RA

The main facility will be used for commercial-scale production of the company’s vaccines and is said to provide twice the cGMP production capacity of their current facility. Novavax

The development of therapeutic will make use of Intrexon’s UltraVector platform and RheoSwitch Therapeutic System. Adeona will utilize Intrexon’s transgene engineering platform for the controlled, precise and continuous

The facility will house expanded US Operations Center, which will comprise manufacturing suite, product development laboratories and administrative offices. The expansion is expected to generate jobs in the

The study comprised 1,014 people who consumed margarine supplemented with daily recommended doses of Omega-3 fatty acids (either 400 mg/day EPA-DHA, 2 g/day ALA, a combination of all

Revlimid is used to treat patients with transfusion-dependent anemia due to low-or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. Patients with MDS develop severe

In 2009, Edbrooke joined Healogix as chief business officer where he led the company through the most significant growth phase. Previously joining to Healogix, Edbrooke was the chief